keryx biopharmaceuticals
(KERX:NASDAQ CM)
Key Executives - keryx biopharmaceuticals (KERX)
| Name | Board Relationships | Title | Age |
| Ron Bentsur | 13 Relationships | Chief Executive Officer, Director and Member of Research & Development Committee | 46 |
| James F. Oliviero CFA | No Relationships | Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer | 36 |
| Lauren Fischer | No Relationships | Director of Investor Relations | -- |
| Amit Sharma M.D., FACP, FASN | 27 Relationships | Vice President of Medical Affairs | -- |
Board Members - keryx biopharmaceuticals (KERX)
| Name | Board Relationships | Primary Company | Age |
| Michael P. Tarnok M.D. | 5 Relationships | Keryx Biopharmaceuticals Inc. | 57 |
| Ron Bentsur | 13 Relationships | Keryx Biopharmaceuticals Inc. | 46 |
| Jack L. Kaye CPA | 5 Relationships | Keryx Biopharmaceuticals Inc. | 68 |
| Kevin J. Cameron J.D. | 20 Relationships | ECOtality, Inc. | 44 |
| Wyche Fowler Jr., J.D. | 46 Relationships | Keryx Biopharmaceuticals Inc. | 71 |
Executive Committees* - keryx biopharmaceuticals (KERX)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | Jack L. Kaye CPA | 5 Relationships | 4 Executives |
| Compensation Committee | Kevin J. Cameron J.D. | 20 Relationships | 3 Executives |
| Recently Viewed | |||
| KERX:US | $8.03 USD | +0.15 | |
| Company | Last | Change |
| Cell Therapeutics Inc | $1.22 USD | -0.07 |
| Curis Inc | $3.78 USD | +0.08 |
| Exact Sciences Corp | $10.54 USD | -0.04 |
| Immunomedics Inc | $3.28 USD | +0.14 |
| Navidea Biopharmaceuticals Inc | $2.50 USD | +0.10 |
| View Industry Companies | ||
Industry Analysis
KERX
Industry Average
| Valuation | KERX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 89.7x |
|
| Price/Book | 7.8x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 81.5x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact KERYX BIOPHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








